Teleflex Incorporated Teleflex Incorporated

Teleflex Incorporated

TFX

Ранг среди акций #3216
Teleflex Incorporated is a global medical technology company dedicated to... Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
Цена акции
$131.01
Рыночная капитализация
$5.55B
Изменение (1 день)
1.10%
Изменение (1 год)
0.36%
Страна
US
Торговля Teleflex Incorporated (TFX)

Категория

Healthcare
Коэффициент P/E для Teleflex Incorporated (TFX)
Коэффициент P/E на October 2026 TTM: -5.30
Согласно последним финансовым отчетам и цене акций Teleflex Incorporated, текущий P/E (TTM) составляет -5.30. В конце 2023 у компании был P/E на уровне 32.87.
История P/E компании Teleflex Incorporated с 2000 по 2026
P/E на конец каждого года
Год P/E коэффициент Изменить
2026 (TTM) -5.30 -104.43%
2024 119.64 263.93%
2023 32.87 1.97%
2022 32.24 1.85%
2021 31.65 -44.52%
2020 57.06 51.40%
2019 37.69 -35.92%
2018 58.81 -19.89%
2017 73.41 149.60%
2016 29.41 31.84%
2015 22.31 -11.85%
2014 25.31 -1.03%
2013 25.57 -266.80%
2012 -15.33 -299.68%
2011 7.68 -28.10%
2010 10.68 51.16%
2009 7.06 -57.34%
2008 16.56 -1.95%
2007 16.89 -8.27%
2006 18.41 -3.49%
2005 19.08 -91.25%
2004 218.11 1,134.01%
2003 17.68 32.21%
2002 13.37 -18.05%
2001 16.31 5.58%
2000 15.45 0.00%
P/E для схожих компаний или конкурентов
Компания P/E Ratio Разница P/E Страна
47.48 -996.61%
US
27.43 -617.86%
FR
- -
JP
56.89 -1,174.29%
US
- -
CH
Как читать P/E Ratio?

Коэффициент цена/прибыль (P/E Ratio) отражает соотношение между ценой акции компании и её прибылью на акцию.
Низкий, но положительный P/E говорит о том, что компания приносит высокую прибыль при низкой оценке и может быть недооценена. Высокий отрицательный (близкий к 0) P/E указывает на значительные убытки.

Компании с P/E выше 30 или отрицательным считаются "акциями роста" — инвесторы ожидают роста или будущей прибыли.

Компании с положительным P/E ниже 10 считаются "ценностными акциями", т.е. уже прибыльны, но с низким потенциалом роста.